EUVIMEDEUVIMED entdecken
Crossref

Luteolin-Manganese Nanozyme Induces Apoptosis and Ferroptosis for Enhanced Cancer Therapy

Gang Xiang, Hui Wang, Changfang Lu, Siyuan Yu, Aimin Wu, Xianxiang Wang iD

Inorganic Chemistry · 2025

DOI: 10.1021/acs.inorgchem.4c05083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inorganic Chemistry, 2025. Verfasst von Gang Xiang und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Agronomy, Sichuan Agricultural University, Chengdu 611130, China. Hauptthemen laut MEDLINE: Luteolin, Ferroptosis, Apoptosis, Antineoplastic Agents. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer presents a significant global public health challenge that impacts millions of individuals worldwide. The incorporation of natural products into cancer treatment has the potential to mitigate many of the side effects commonly associated with chemotherapy. This study builds on the advantages of enhancing the anticancer activity of natural flavonoids through metal chelation by synthesizing a natural antioxidant flavonoid complex, termed Lu-Mn nanozyme, which involves the chelation of luteolin with manganese ions. In vitro experiments demonstrated that Lu-Mn exhibits a strong affinity for hydrogen peroxide (H2O2) and effectively catalyzes the generation of hydroxyl radicals (•OH) from H2O2 within the tumor microenvironment. The administration of the Lu-Mn nanozyme not only induced apoptosis in tumor cells by upregulating the expression of cleaved caspase3 and caspase9 but also activated ferroptosis through downregulation of the NRF2-GPX4 signaling pathway. Furthermore, animal studies have shown that Lu-Mn possesses significant antitumor efficacy and a favorable safety profile. Collectively, these findings suggest that luteolin, through its chelation with metal ions, has considerable potential for application in cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LuteolinFerroptosisApoptosisAntineoplastic AgentsManganeseCoordination ComplexesHumansAnimalsMiceDrug Screening Assays, AntitumorCell Line, TumorCell Proliferation

Substanzen

LuteolinAntineoplastic AgentsManganeseCoordination Complexes

Autor:innen und Institutionen

  • College of Agronomy, Sichuan Agricultural University, Chengdu 611130, China.
  • College of Science, Sichuan Agricultural University, Chengdu, Sichuan 611130, China.
  • Institute of Animal Nutrition, Sichuan Agricultural University, Chengdu 611130, China.

ORCID-Profile: Xianxiang Wang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xiang, G., Wang, H., Lu, C., Yu, S., Wu, A., & Wang, X. (2025). Luteolin-Manganese Nanozyme Induces Apoptosis and Ferroptosis for Enhanced Cancer Therapy. Inorganic Chemistry. https://doi.org/10.1021/acs.inorgchem.4c05083

Vancouver

Xiang G, Wang H, Lu C, Yu S, Wu A, Wang X. Luteolin-Manganese Nanozyme Induces Apoptosis and Ferroptosis for Enhanced Cancer Therapy. Inorganic Chemistry. 2025. doi:10.1021/acs.inorgchem.4c05083

BibTeX
@article{Xiang2025,
  author = {Xiang, Gang and Wang, Hui and Lu, Changfang and Yu, Siyuan and Wu, Aimin and Wang, Xianxiang},
  title = {Luteolin-Manganese Nanozyme Induces Apoptosis and Ferroptosis for Enhanced Cancer Therapy},
  journal = {Inorganic Chemistry},
  year = {2025},
  doi = {10.1021/acs.inorgchem.4c05083}
}
Kostenlos starten →